A Case of Acute Hyperglycemia Induced by Jerusalem Artichoke in a Patient with Type 2 Diabetes Mellitus.
10.4093/jkd.2016.17.3.212
- Author:
Seung Jae JANG
1
;
Jung Min KIM
;
Jun Hee BANG
;
Young Gon JUNG
;
Suk Je JIN
;
Yong Jin JEONG
;
Byung Ki KIM
;
Mi Yeon KANG
Author Information
1. Department of Internal Medicine, St. Carollo Hospital, Suncheon, Korea. leerabin@hanmail.net
- Publication Type:Case Report
- Keywords:
Diabetes mellitus;
Helianthus;
Inulin
- MeSH:
Blood Glucose;
Diabetes Mellitus;
Diabetes Mellitus, Type 2*;
Fructans;
Glucose;
Helianthus*;
Humans;
Hyperglycemia*;
Inpatients;
Insulin;
Inulin
- From:Journal of Korean Diabetes
2016;17(3):212-218
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Jerusalem artichoke (JA) mainly consists of inulin. In many experimental studies, inulin has been shown to be beneficial for decreasing glucose level. Therefore, JA is lately attracting wide attention as an anti-diabetic food. Therefore, many patients ingest JA in extract form. However, there are no published clinical studies in patients with diabetes to demonstrate benefit from the use of inulin-type fructans. We experienced a diabetes inpatient with acute hyperglycemia associated with JA. We could not control the patient's blood glucose in spite of addition and increment of insulin. We found that she had taken extracts of JA and recommended cessation. After discontinuing JA extracts, her blood glucose was well controlled in spite of discontinuation of insulin. Thus, in this patient, JA had actually increased blood glucose. We suggest that JA may be dangerous for use in diabetic patients.
